Cargando…
Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial
OBJECTIVE: To compare the efficacy and safety of recombinant anti-D (R-anti-D) with conventional polyclonal anti-D (Poly anti-D) in preventing maternal-fetal rhesus D (RhD) alloimmunization and to investigate the immunogenicity of R-anti-D. METHODS: This was a randomized, open-label, multi-center cl...
Ejemplares similares
-
A study of transobturator tape in stress urinary incontinence
por: Mayekar, Rahul Vishwanath, et al.
Publicado: (2017) -
Foetal and neonatal alloimmune thrombocytopaenia
por: Kaplan, Cecile
Publicado: (2006) -
A Multicenter, Randomized, Equivalence Trial of a New Recombinant Human Chorionic Gonadotropin Preparation versus Ovitrelle(®) for Ovulation in Women Undergoing Intrauterine Insemination Following Ovarian Stimulation
por: Majumdar, Abha, et al.
Publicado: (2019) -
The combined effect of anti-D and non-D Rh antibodies in maternal alloimmunization
por: Gedik Özköse, Zeynep, et al.
Publicado: (2021) -
“Science means learning to say—I don’t know”: An interview with Dr. Ashok D.B. Vaidya
por: Pandharinath, Ravindra R.
Publicado: (2011)